wegovy is tirzepatide Zepbound (tirzepatide) superior to (semaglutide), says Lilly-funded clinical trial Comparing Oral and Injectable Forms

Researched and written by the author

This efficient approach saves you time and removes the guesswork from navigating complex insurance requirements

In phase 3 adult clinical trials, most notably the SURMOUNT-1 study, tirzepatide produced significant and sustained reductions in body weight and metabolic parameters

Convenient and easy to use: Our injection is quick and easy to administer, with no downtime or recovery required

We do ask new patients to fill out brief intake paperwork on their first visit (about 5 minutes)

The second experimental group (n = 10) received the drug subcutaneously at a dose of 0.04 mg/kg (1/10 of 2000 mg/kg)